Evofem Biosciences, Inc. (EVFM)
OTCMKTS
· Delayed Price · Currency is USD
0.0086
-0.0001 (-1.15%)
Apr 29, 2026, 3:57 PM EST
Evofem Biosciences Employees
Evofem Biosciences had 29 employees as of December 31, 2025. The number of employees decreased by 3 or -9.38% compared to the previous year.
Employees
29
Change (1Y)
-3
Growth (1Y)
-9.38%
Revenue / Employee
$695,966
Profits / Employee
$9,448
Market Cap
1.15M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| LakeShore Biopharma | 573 |
| Abpro Holdings | 3 |
| CERo Therapeutics Holdings | 8 |
| GB Sciences | 2 |
| Lyra Therapeutics | 27 |
| Windtree Therapeutics | 14 |
| International Stem Cell | 33 |
| Adaptimmune Therapeutics | 506 |
Evofem Biosciences News
- 2 days ago - Evofem Announces Exclusive Agreement for the Distribution and Commercialization of SOLOSEC in Sub-Saharan Africa - Business Wire
- 7 weeks ago - Evofem Reports Fifth Consecutive Year of Net Sales Growth - Business Wire
- 3 months ago - Evofem CEO Saundra Pelletier Calls for a “Ground-Up Reset” of Women's Health at Fierce JPM Week 2026 - Business Wire
- 3 months ago - Evofem Expands “Say Vagina” Campaign With Launch of Say Vagina Store - Business Wire
- 5 months ago - Favorable Pricing Certificates Issued for Evofem's PHEXX by Emirates Drug Establishment are Launching Step for Commercialization in UAE - PRNewsWire
- 5 months ago - Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update - PRNewsWire
- 6 months ago - Evofem Announces Voting Results from Special Meeting of Stockholders - PRNewsWire
- 7 months ago - Evofem's SOLOSEC Submitted for Marketing Approval in United Arab Emirates - PRNewsWire